{"metadata": {"source": "erowid", "title": "Erowid Oxycodone Vault : Timeline", "description": "A timeline of events in the history of Oxycodone", "language": "No language found.", "url": "https://www.erowid.org/pharms/oxycodone/oxycodone_timeline.php", "drug": "Oxycodone", "cid": 5284603, "substance": "oxycodone", "category": "PHARMS", "erowid_column": "History", "char_count": 4624, "word_count": 638, "doc_id": "doc_210", "num_chunks": 6, "chunk_id": "210::chunk_4", "document_index": 210, "latency_s": 0.9409597000048961, "prompt_toks": 1671, "completion_toks": 78, "relevance_score": 0.00011591935}, "content": "Drug: Oxycodone | cid: 5284603\nSource: erowid | Source description: A timeline of events in the history of Oxycodone\nErowid name: oxycodone\nCategory: PHARMS\nField: History\n\n                    Text: \n                    Oxycodone\n\nTimeline\n\nby Erowid\n\n1916 Oxycodone was first synthesized in Germany as a semi-synthetic derivative of thebaine. 1 1917 Oxycodone is first introduced into clinical practice in Germany under the brand name Eukodal. 2 , 3 1920s Reports first surface of Oxycodone causing \"euphoric highs\" in patients. [More Info] 1950 Percodan (oxycodone and aspirin combo) is first launched by Endo Pharmaceutical. [More Info] 1960 The United Nation Office on Drug and Crime includes oxycodone in the Dangerous Drugs (Amendment) Ordinance. 1971 Percocet (oxycodone and acetaminophen combo) is first launched by Endo Pharmaceutical. [More Info] 1995 The FDA approves a higher-dose time-release form of Oxycodone under the brand name OxyContin, owned by Purdue Pharma. 1996 OxyContin becomes publicly available.  Recreational use and abuse of oxycodone increases. 2001 OxyContin faces significant national media attention in the U.S. because of increases in recreational use and abuse.\n\nReferences\n\n\n                    Context: \n                    This chunk provides a detailed timeline of oxycodone's synthesis, medical introduction, and regulatory history from 1916 to 2001, sourced from Erowid. It is relevant for understanding the historical development, medical use, and abuse trends of oxycodone within the broader context of drugs and pharmaceuticals covered in the full webpage. The references included support key historical milestones.\n                "}
{"metadata": {"source": "erowid", "title": "Erowid Oxycodone Vault : Timeline", "description": "A timeline of events in the history of Oxycodone", "language": "No language found.", "url": "https://www.erowid.org/pharms/oxycodone/oxycodone_timeline.php", "drug": "Oxycodone", "cid": 5284603, "substance": "oxycodone", "category": "PHARMS", "erowid_column": "History", "char_count": 4624, "word_count": 638, "doc_id": "doc_210", "num_chunks": 6, "chunk_id": "210::chunk_4", "document_index": 210, "latency_s": 0.9409597000048961, "prompt_toks": 1671, "completion_toks": 78, "relevance_score": 0.00011591935}, "content": "Drug: Oxycodone | cid: 5284603\nSource: erowid | Source description: A timeline of events in the history of Oxycodone\nErowid name: oxycodone\nCategory: PHARMS\nField: History\n\n                    Text: \n                    Oxycodone\n\nTimeline\n\nby Erowid\n\n1916 Oxycodone was first synthesized in Germany as a semi-synthetic derivative of thebaine. 1 1917 Oxycodone is first introduced into clinical practice in Germany under the brand name Eukodal. 2 , 3 1920s Reports first surface of Oxycodone causing \"euphoric highs\" in patients. [More Info] 1950 Percodan (oxycodone and aspirin combo) is first launched by Endo Pharmaceutical. [More Info] 1960 The United Nation Office on Drug and Crime includes oxycodone in the Dangerous Drugs (Amendment) Ordinance. 1971 Percocet (oxycodone and acetaminophen combo) is first launched by Endo Pharmaceutical. [More Info] 1995 The FDA approves a higher-dose time-release form of Oxycodone under the brand name OxyContin, owned by Purdue Pharma. 1996 OxyContin becomes publicly available.  Recreational use and abuse of oxycodone increases. 2001 OxyContin faces significant national media attention in the U.S. because of increases in recreational use and abuse.\n\nReferences\n\n\n                    Context: \n                    This chunk provides a detailed timeline of oxycodone's synthesis, medical introduction, and regulatory history from 1916 to 2001, sourced from Erowid. It is relevant for understanding the historical development, medical use, and abuse trends of oxycodone within the broader context of drugs and pharmaceuticals covered in the full webpage. The references included support key historical milestones.\n                "}
{"metadata": {"source": "pubchem", "title": "Oxycodone | C18H21NO4 | CID 5284603 - PubChem", "description": "Oxycodone | C18H21NO4 | CID 5284603 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5284603", "drug": "Oxycodone", "cid": 5284603, "char_count": 168604, "word_count": 22166, "doc_id": "doc_54", "num_chunks": 238, "chunk_id": "54::chunk_26", "document_index": 54, "latency_s": 1.5990312999929301, "prompt_toks": 45443, "completion_toks": 81, "relevance_score": 3.734357e-05}, "content": "Drug: Oxycodone | cid: 5284603\nSource: pubchem | Source description: Oxycodone | C18H21NO4 | CID 5284603 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Form;Route\n\nTABLET, EXTENDED RELEASE;ORAL\n\nCompany\n\nPURDUE PHARMA LP\n\nDate\n\n12/15/23\n\n2 of 2\n\nDrug\n\nActive Ingredient\n\nForm;Route\n\nCompany\n\nDate\n\nDrug\n\nXTAMPZA ER\n\nActive Ingredient\n\nOXYCODONE\n\nForm;Route\n\nCAPSULE, EXTENDED RELEASE;ORAL\n\nCompany\n\nCOLLEGIUM PHARM INC\n\nDate\n\n12/15/23\n\n7.5 WHO Essential Medicines\n\nDrug\n\nDrug Classes\n\nFormulation\n\nIndication\n\nDrug\n\nOxycodone\n\nDrug Classes\n\nOpioid analgesics\n\nFormulation\n\nIndication\n\nPain\n\n7.6 FDA Approved Drugs\n\n7.7 FDA Orange Book\n\n7.8 FDA National Drug Code Directory\n\n7.9 Drug Labels\n\nDrug and label\n\nActive ingredient and drug\n\n7.10 Clinical Trials\n\n7.10.1 ClinicalTrials.gov\n\n7.10.2 EU Clinical Trials Register\n\n7.10.3 NIPH Clinical Trials Search of Japan\n\n7.11 DEA Drug and Chemical Information\n\nOxycodone\n\n(Trade Names:Tylox®, Percodan®, OxyContin®)\n\n7.11.1 DEA Controlled Substances\n\n1 of 2\n\nSubstance\n\nOxycodone\n\nDEA Controlled Substances Code Number\n\n9143\n\nControlled Substances Act Schedule\n\n\n                    Context: \n                    This section provides detailed information on commercially available oxycodone formulations, including extended-release tablets and capsules from Purdue Pharma LP, with specific product names like XTAMPZA ER. It also summarizes oxycodone's drug classification, formulation, indications, regulatory approval status, and controlled substance scheduling, situating it within the broader context of chemical, pharmacological, and regulatory data compiled in the full document.\n                "}
